Albuminuria
Glutamine with Sitagliptin → Albuminuria
Glutamine with Sitagliptin → Albuminuria
Evidence profile
Key finding
HbA1c decreased (P = 0.007)
Daily oral supplementation of glutamine with or without sitagliptin in well-controlled type 2 diabetes patients.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Glutamine with Sitagliptin
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Primary outcome
HbA1c
Comparator
Glutamine + Placebo
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
Daily oral supplementation of glutamine with or without sitagliptin in well-controlled type 2 diabetes patients.
This study evaluated Daily oral supplementation of glutamine with or without sitagliptin in well-controlled type 2 diabetes patients.
Limitations were not clearly described in the extracted text.
Published in
Publication details and source links for this paper.
Dorit S, Donald JC, Fiona MG, et al. Daily oral supplementation of glutamine with or without sitagliptin decreases glycaemia in type 2 diabetes patients. PLoS ONE. 2014;9(11):e113366. doi:10.1371/journal.pone.0113366
Save this study and add notes to your research library.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Glutamine with Sitagliptin and Albuminuria, Blood urea nitrogen (BUN), Body weight, and 8 more.
This study contributes evidence to
Primary intervention
Glutamine with Sitagliptin
Primary outcomes
Evidence topics
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
3
Related topics
11
Evidence pairs
260
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Glutamine with Sitagliptin → Albuminuria
Glutamine with Sitagliptin → Albuminuria
Evidence profile
Glutamine with Sitagliptin → Blood urea nitrogen (BUN)
Glutamine with Sitagliptin → Blood urea nitrogen (BUN)
Evidence profile
Glutamine with Sitagliptin → Body weight
Glutamine with Sitagliptin → Body weight
Evidence profile
Glutamine with Sitagliptin → Estimated glomerular filtration rate
Glutamine with Sitagliptin → Estimated glomerular filtration rate
Evidence profile
Glutamine with Sitagliptin → Fructosamine
Glutamine with Sitagliptin → Fructosamine
Evidence profile
Glutamine with Sitagliptin → HbA1c
Glutamine with Sitagliptin → HbA1c
Evidence profile
Glutamine with Sitagliptin → Hematocrit
Glutamine with Sitagliptin → Hematocrit
Evidence profile
Glutamine with Sitagliptin → Hemoglobin
Glutamine with Sitagliptin → Hemoglobin
Evidence profile
Glutamine with Sitagliptin → Plasma Electrolytes
Glutamine with Sitagliptin → Plasma Electrolytes
Evidence profile
Glutamine with Sitagliptin → Red Blood Cells
Glutamine with Sitagliptin → Red Blood Cells
Evidence profile
Glutamine with Sitagliptin → Serum creatinine
Glutamine with Sitagliptin → Serum creatinine
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on DPP-4 Inhibitors and Kidney Function, DPP-4 Inhibitors and Fructosamine.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies on DPP-4 Inhibitors
Contributes to DPP-4 Inhibitors evidence base.
All studies measuring Fructosamine
Measures Fructosamine as a key outcome.
All studies measuring Kidney Function
Measures Kidney Function as a key outcome.
Jump to pre-filtered views in the evidence archive.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
DPP-4 Inhibitors appears to improve HbA1c.
ConsensusScore™: Results are consistent across studies.
Ranked evidence signals
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on 7 supporting studies with consistent results and a positive effect signal.
Limitations
DPP-4 Inhibitors may improve Body Weight.
ConsensusScore™: Results are mixed and should be interpreted cautiously.
Ranked evidence signals
Body weight
EvidenceScore™ Limited | EvidenceScore™ 33.0 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
Current evidence does not show a clear benefit of DPP-4 Inhibitors for Kidney Function.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Albuminuria
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Estimated glomerular filtration rate
EvidenceScore™ Limited | EvidenceScore™ 33.0 | neutral | ConsensusScore™ Unclear | 1 study
Serum creatinine
EvidenceScore™ Limited | EvidenceScore™ 33.0 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Glutamine with Sitagliptin appears to improve Fructosamine.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Fructosamine
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Follow the topics this study contributes to.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.